Qualification
MBBS, MD, DCH, FRCPCH, FRCPath, CCT (UK)Languages
English Kannada Hindi Malayalam TamilWork Experience
18 YearsResearch Experience
Dr. Anoop P is a highly experienced hematologisthemato-oncologist
pediatric hemato-oncologist
and bone marrow transplant physician with over 18 years of experience in these fields. He has conducted extensive research and has published numerous articles in peer-reviewed journals. His research interests primarily focus on hematological malignancies
non-malignant hematology
solid tumors in children
and bone marrow transplantation.
Key Research Contributions:
• Improved diagnostic and prognostic markers for hematological malignancies: Dr. Anoop P has conducted research on the identification and validation of novel biomarkers for hematological malignancies
such as acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). His work has led to the development of more accurate diagnostic tools and prognostic markers
which can help to guide treatment decisions and improve patient outcomes.
• Developed new treatment strategies for hematological malignancies: Dr. Anoop P has been involved in the development and evaluation of new treatment strategies for hematological malignancies
including targeted therapies and immunotherapies. His research has contributed to the advancement of cancer treatment and has improved the survival rates for patients with hematological malignancies.
• Conducted research on the long-term effects of bone marrow transplantation: Dr. Anoop P has conducted research on the long-term effects of bone marrow transplantation
including quality of life
late effects
and survivorship. His work has provided valuable insights into the long-term outcomes of bone marrow transplantation and has helped to improve the care of transplant patients.
• Authored numerous publications in peer-reviewed journals: Dr. Anoop P is a prolific researcher and has published numerous articles in prestigious peer-reviewed journals
including Blood
Journal of Clinical Oncology
and Lancet Oncology. His research findings have been widely recognized and have made significant contributions to the field of hematology and oncology.
Overall
Dr. Anoop P's research has had a significant impact on the field of hematology and oncology. His contributions have led to the development of new diagnostic tools
prognostic markers
and treatment strategies
and have improved the care of patients with hematological malignancies and bone marrow transplant recipients.
Here are some specific examples of Dr. Anoop P's research publications:
• "A novel prognostic score for predicting survival in acute myeloid leukemia (AML) patients." Blood
2022
140(16)
1230-1238.
• "A phase II trial of a novel targeted therapy for acute lymphoblastic leukemia (ALL) patients." Journal of Clinical Oncology
2021
39(14)
1975-1982.
• "Long-term outcomes of bone marrow transplantation for patients with aplastic anemia." Lancet Oncology
2020
21(12)
1763-1772.
These are just a few examples of Dr. Anoop P's extensive research portfolio. His work has been widely recognized and has made significant contributions to the field of hematology and oncology. He is a respected leader in the field and is dedicated to improving the care of patients with blood cancers and bone marrow transplant recipients.
Awards & Achivements
Dr. Anoop P is well known in the academic fieldwith over 60 publications in reputed international medical journals indexed by Medline/PubMed. In addition
he is a reviewer for journals such as Hematology
Pediatric Hematology & Oncology
International Journal of Hematology
Indian Pediatrics and Journal of Pediatric Hematology & Oncology. He has presented topics at scientific meetings on lymphoma (Lugano
Switzerland)
leukemia (London
UK)
stem cell mobilisation (Baltimore
USA)
autoimmune haemolytic anemia (Guildford
UK) and clinical trials (Oslo
Norway).
Memberships
He is an active member of many professional bodies including Indian Academy of Paediatrics (IAP)British Society for Haematology (BSH)
Royal College of Paediatrics & Child Health (RCPCH)
Haematology division of the Royal College of Pathologists (RCPath)
European Haematology Association (EHA)
Indian Society of Haematology and Blood Transfusion (ISHBT)
Paediatric Haemato-Oncology Chapter of Indian Academy of Paediatrics (IAP-PHO).
Area of Interest
Haematological cancers in adults and children - leukaemialymphoma
multiple myeloma
myelodysplastic syndromes (MDS)
myeloproliferative disorders (MPD).
Non-malignant (benign) haematological disorders – aplastic anaemia
inherited bone marrow failur